Key facts
- This page summarizes Albert Bourla's Form 4 filing for PFIZER INC (PFE).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 25 Feb 2025, 19:06.
Albert Bourla - 22 Feb 2025 Form 4 Insider Report for PFIZER INC (PFE)
- Reporting relationship
- Chairman & CEO, Director
- Issuer ticker
- PFE
- Reported as of
- 22 Feb 2025
- Net transaction value
- +$1,413,443
- SEC form
- 4
- Accepted by SEC
- 25 Feb 2025, 19:06:33 UTC
- Prior SEC filing
- 18 Feb 2025
- Next SEC filing
- 03 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Shanice A. Reid, by power of atty., for Albert Bourla
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Albert Bourla filed Form 4 for PFIZER INC (PFE) on 25 Feb 2025.
Change
- Previous filing in this sequence was filed on 18 Feb 2025.
- Current net transaction value: +$1,413,443.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PFE
transaction
Common Stock
Options Exercise
- Transaction value
- $7,192,498
- Shares
- +238,399
- Change %
- +72%
- Price
- $30.17
- Shares after
- 570,436
- Date
- 22 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
PFE
transaction
Common Stock
Tax liability
- Transaction value
- $232,360
- Shares
- -8,835
- Change %
- -1.5%
- Price
- $26.30
- Shares after
- 561,601
- Date
- 22 Feb 2025
- Ownership
- Direct
- Footnotes
- F2, F3
PFE
transaction
Common Stock
Tax liability
- Transaction value
- $5,546,694
- Shares
- -212,680
- Change %
- -38%
- Price
- $26.08
- Shares after
- 348,921
- Date
- 22 Feb 2025
- Ownership
- Direct
- Footnotes
- F4, F5
PFE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,357
- Date
- 22 Feb 2025
- Ownership
- By Rule 16b-3 Plan
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PFE
transaction
Derivative
Stock Appreciation Rights
Options Exercise
- Transaction value
- $0
- Shares
- -238,399
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 22 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 238,399
- Exercise price
- $30.17
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
Footnote F2
The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
Footnote F3
Price is the closing price of Pfizer common stock on February 21, 2025.
Footnote F4
The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
Footnote F5
Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.